Cargando…

AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study

BACKGROUND: Most hepatocellular carcinoma (HCC) patients’ liver function indexes are abnormal. We aimed to investigate the relationship between (alkaline phosphatase + gamma-glutamyl transpeptidase)/lymphocyte ratio (AGLR) and the progression as well as the prognosis of HCC. METHODS: A total of 495...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Yan, Wei, Rongyu, Yao, Renzhi, Qin, Liling, Li, Jun, Yu, Junxiong, Liao, Weijia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860009/ https://www.ncbi.nlm.nih.gov/pubmed/33536005 http://dx.doi.org/10.1186/s12893-020-01037-7

Ejemplares similares

Prognostic Value of Gamma-Glutamyl Transpeptidase to Lymphocyte Count Ratio in Patients With Single Tumor Size ≤ 5 cm Hepatocellular Carcinoma After Radical Resection
por: Liao, Minjun, et al.
Publicado: (2019)

Prospect of Circular RNA in Hepatocellular Carcinoma: A Novel Potential Biomarker and Therapeutic Target
por: Yao, Renzhi, et al.
Publicado: (2018)

A novel prognostic index—neutrophil times γ-glutamyl transpeptidase to lymphocyte ratio (NγLR) predicts outcome for patients with hepatocellular carcinoma
por: Li, Jun, et al.
Publicado: (2017)

Data mining of the expression and regulatory role of BCAT1 in hepatocellular carcinoma
por: Zou, Haifan, et al.
Publicado: (2019)

Preoperative high-sensitivity C-reactive protein to lymphocyte ratio index plays a vital role in the prognosis of hepatocellular carcinoma after surgical resection
por: Liao, Minjun, et al.
Publicado: (2018)

Preoperative Radiomics Analysis of Contrast-Enhanced CT for Microvascular Invasion and Prognosis Stratification in Hepatocellular Carcinoma
por: Xu, Tingfeng, et al.
Publicado: (2022)

The Significance of Gamma-Glutamyl Transpeptidase to Lymphocyte Count Ratio in the Early Postoperative Recurrence Monitoring and Prognosis Prediction of AFP-Negative Hepatocellular Carcinoma
por: Li, Siming, et al.
Publicado: (2021)

Up-regulation of BRCA1-associated RING Domain 1 Promotes Hepatocellular Carcinoma Progression by Targeting Akt Signaling
por: Liao, Yan, et al.
Publicado: (2017)

Upregulation of RECQL4 expression predicts poor prognosis in hepatocellular carcinoma
por: Li, Jun, et al.
Publicado: (2018)

Elevation of MAP17 enhances the malignant behavior of cells via the Akt/mTOR pathway in hepatocellular carcinoma
por: Chen, Xinhuang, et al.
Publicado: (2017)

Preoperative prediction of hepatocellular carcinoma with portal vein tumor thrombus based on conventional data
por: Zhu, Pengpeng, et al.
Publicado: (2017)

High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma
por: Liao, Weijia, et al.
Publicado: (2014)

Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resection
por: Jin, Junfei, et al.
Publicado: (2015)

A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma
por: Zhu, Pengpeng, et al.
Publicado: (2015)

Predictive potential of Nomogram based on GMWG for patients with hepatocellular carcinoma after radical resection
por: Ren, Liying, et al.
Publicado: (2021)

A Novel Post-Operative ALRI Model Accurately Predicts Clinical Outcomes of Resected Hepatocellular Carcinoma Patients
por: Liao, Minjun, et al.
Publicado: (2021)

Preoperative Neutrophil-to-Lymphocyte Ratio as a New Prognostic Marker in Hepatocellular Carcinoma after Curative Resection()
por: Liao, Weijia, et al.
Publicado: (2014)

FOXP3 gene polymorphism is associated with hepatitis B-related hepatocellular carcinoma in China
por: Chen, YanHui, et al.
Publicado: (2013)

An Apoptotic Gene Signature for the Prognosis of Hepatocellular Carcinoma
por: Chen, Kunlun, et al.
Publicado: (2021)

The role of kinesin KIF18A in the invasion and metastasis of hepatocellular carcinoma
por: Luo, Weiwei, et al.
Publicado: (2018)

Silencing of DLGAP5 by siRNA Significantly Inhibits the Proliferation and Invasion of Hepatocellular Carcinoma Cells
por: Liao, Weijia, et al.
Publicado: (2013)

Prognostic nutritional index predicts prognosis in patients with metastatic nasopharyngeal carcinoma
por: Wei, Gan-Bao, et al.
Publicado: (2016)

Risk Predictive Model Based on Three DDR-Related Genes for Predicting Prognosis, Therapeutic Sensitivity, and Tumor Microenvironment in Hepatocellular Carcinoma
por: Hu, Renzhi, et al.
Publicado: (2022)

The preoperative alkaline phosphatase-to-platelet ratio index is an independent prognostic factor for hepatocellular carcinoma after hepatic resection
por: Yu, Ya-Qun, et al.
Publicado: (2016)

Preoperative Aspartate Aminotransferase to White Blood Cell Count Ratio Predicting Postoperative Outcomes of Hepatocellular Carcinoma
por: Liao, Weijia, et al.
Publicado: (2016)

Ferroportin in the progression and prognosis of hepatocellular carcinoma
por: Wang, Qin, et al.
Publicado: (2013)

AGO1 may influence the prognosis of hepatocellular carcinoma through TGF-β pathway
por: Wang, Miao, et al.
Publicado: (2018)

Development of an Aerobic Glycolysis Index for Predicting the Sorafenib Sensitivity and Prognosis of Hepatocellular Carcinoma
por: Pan, Yu, et al.
Publicado: (2021)

Postoperative aspartate aminotransferase to platelet ratio index change predicts prognosis for hepatocellular carcinoma
por: Peng, Wei, et al.
Publicado: (2016)

A Novel Gene Pair CSTF2/DPE2A Impacts Prognosis and Cell Cycle of Hepatocellular Carcinoma
por: Huang, Yangjin, et al.
Publicado: (2023)

TTK activates Akt and promotes proliferation and migration of hepatocellular carcinoma cells
por: Liu, Xing, et al.
Publicado: (2015)

A novel hypoxia gene signature indicates prognosis and immune microenvironments characters in patients with hepatocellular carcinoma
por: Zhang, Qiangnu, et al.
Publicado: (2021)

A Novel Nomogram to Predict Prolonged Survival After Hepatectomy in Repeat Recurrent Hepatocellular Carcinoma
por: Fang, Qiongxuan, et al.
Publicado: (2021)

Curcumin inhibits hepatocellular carcinoma growth by targeting VEGF expression
por: Pan, Zirong, et al.
Publicado: (2018)

Circulating immune index predicting the prognosis of patients with hepatocellular carcinoma treated with lenvatinib and immunotherapy
por: Guo, De-Zhen, et al.
Publicado: (2023)

Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma
por: Liao, Weijia, et al.
Publicado: (2015)

Prediction of early treatment response to the combination therapy of TACE plus lenvatinib and anti-PD-1 antibody immunotherapy for unresectable hepatocellular carcinoma: Multicenter retrospective study
por: Li, Shuqun, et al.
Publicado: (2023)

Retraction Note: Ferroportin in the progression and prognosis of hepatocellular carcinoma
por: Wang, Qin, et al.
Publicado: (2015)

A Powerful Nomogram Based on the Novel D-Index to Predict Prognosis After Surgical Resection of Hepatocellular Carcinoma
por: Du, Xia, et al.
Publicado: (2021)

Systemic inflammation response index (SIRI) predicts prognosis in hepatocellular carcinoma patients
por: Xu, Litao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qe4mjm0m2h33sv429bpfdlj76c